{
    "clinical_study": {
        "@rank": "13392", 
        "arm_group": {
            "arm_group_label": "LAA exclusion procedure", 
            "arm_group_type": "Experimental", 
            "description": "LAA exclusion with the LARIAT RS Suture Delivery Device"
        }, 
        "brief_summary": {
            "textblock": "The objective is to assess the effectiveness of permanent exclusion of the LAA with the\n      LARIAT RS Suture Delivery Device and accessories in AF patients."
        }, 
        "brief_title": "LARIAT RS: An Observational Study of the Performance and Safety of the LARIAT RS", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Atrial Appendage", 
        "detailed_description": {
            "textblock": "Prospective, observational, single-center, non-randomized study of a stand-alone procedure\n      for the exclusion of the LAA with the LARIAT RS in patients with atrial fibrillation.\n      Completed LAA exclusion will be assessed by TEE."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Age \u2265 21 years\n\n          2. Diagnosed non-valvular atrial fibrillation\n\n          3. Current CHADS2 score \u2265 2\n\n          4. Poor candidate (e.g., contraindicated, labile INR, non-compliant, etc.) for\n             anticoagulation (e.g., warfarin, dabigatran, apixaban, and rivaroxaban)\n\n          5. Life expectancy of \u2265 1 year\n\n          6. Willing and able to provide written informed consent\n\n          7. Willing and able to come to and comply with scheduled follow-up visits\n\n        Exclusion Criteria:\n\n          1. Previous cardiac surgery involving opening of pericardium (e.g., CABG, heart\n             transplantation, valve surgery)\n\n          2. Prosthetic heart valve or ring in any position\n\n          3. Current NYHA Class IV heart failure symptoms\n\n          4. Current right heart failure\n\n          5. Myocardial infarction or unstable angina within last 3 months\n\n          6. Current cardiogenic shock or hemodynamic instability\n\n          7. Current symptomatic carotid disease\n\n          8. Need for an intra-aortic balloon pump or intravenous inotropes\n\n          9. Embolic stroke or transient ischemic attack (TIA) within the last 30 days.\n\n         10. Current diagnosis of active systemic infection\n\n         11. Need for emergent cardiac surgery (e.g., cardiogenic shock)\n\n         12. Current renal failure requiring dialysis\n\n         13. Current clinical evidence of cirrhosis\n\n         14. Any history of thoracic radiation\n\n         15. Current use of long term treatment with steroids, not including intermittent use of\n             inhaled steroids for respiratory diseases\n\n         16. Diagnosed autoimmune disease known to be associated with pericarditis (i.e., specific\n             connective tissue disorders)\n\n         17. Any history of pericarditis\n\n         18. Pectus excavatum  (clinically defined by treating physician)\n\n         19. Severe scoliosis\n\n         20. Pregnancy or desire to get pregnant within the next 12 months.\n\n         21. LVEF < 30%\n\n         22. Current participation in a clinical investigation that involves an active treatment\n             arm.\n\n         23. Mental impairment or other conditions, which may not allow patient to understand the\n             nature, significance and scope of the study\n\n         24. Any other criteria, which would make the patient unsuitable to participate in this\n             study as determined by clinical site Principal Investigator  (e.g., an uncontrolled\n             drug and/or alcohol addiction)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02059707", 
            "org_study_id": "RS-003 V1.0_30Oct2012"
        }, 
        "intervention": {
            "arm_group_label": "LAA exclusion procedure", 
            "description": "LARIAT RS Suture Delivery Device", 
            "intervention_name": "LARIAT RS Suture Delivery Device", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 7, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Krakow", 
                    "country": "Poland"
                }, 
                "name": "Jagiellonian University (John Paul II) Hospilal"
            }
        }, 
        "location_countries": {
            "country": "Poland"
        }, 
        "number_of_arms": "1", 
        "official_title": "LARIAT RS: An Observational Study of the Performance and Safety of the LARIAT RS Suture Delivery Device", 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Poland: Office of Registration of Medicinal Products, Medical Devices and Biocides", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To assess the rate of complete exclusion of the LAA measured by color duplex TEE at 4 time points: Acute (i.e., immediately after LAA exclusion procedure), 1 day, 1 month, and 3 month.", 
            "measure": "Percent of subjects with complete exclusion", 
            "safety_issue": "No", 
            "time_frame": "90 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02059707"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The rate of procedural success\nThe rate of complications related to the use of the LARIAT RS and accessories", 
            "measure": "Secondary Exploratory objectives of procedural success and device-related complication rates", 
            "safety_issue": "Yes", 
            "time_frame": "3 month"
        }, 
        "source": "SentreHEART, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "SentreHEART, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}